Lyell Competitors and Similar CompaniesClear all
Lyell's competitors and similar companies include Arvinas and NovoCure.
 Arvinas Arvinas is a biopharmaceutical company focused on developing protein degradation therapeutics for cancers and other diseases. |  NovoCure NovoCure is a company engaged in the development, manufacture, and commercialization of solutions for the treatment of solid tumors. | ||
Founding Date | Founding Date 2018 | Founding Date N/A | Founding Date 2000 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations South San Francisco, US HQ Bothell, US Seattle, US | Locations New Haven, US HQ | |
Employees | Employees 188 | Employees 13329% increase | Employees 1,488 |
Valuation ($) | Valuation ($) 243.3 m | Valuation ($) 1.9 b | Valuation ($) 1.8 b |
Financial | |||
Revenue (est.) | Revenue (est.) $36k (FY, 2025) | Revenue (est.) $262.6m (FY, 2025) | Revenue (est.) $655.4m (FY, 2025) |
Net income | Net income ($274.4m) (FY, 2025) | Net income ($80.8m) (FY, 2025) | Net income ($136.2m) (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Arvinas
HQ
New Haven, US
Employees
133↑ 29% increase
Arvinas is a biopharmaceutical company focused on developing protein degradation therapeutics for cancers and other diseases.
View companyNovoCure
HQ
Saint Helier, JE
Employees
1,488
NovoCure is a company engaged in the development, manufacture, and commercialization of solutions for the treatment of solid tumors.
View company